Palatin Technologies (PTN) Tops Q1 EPS by 1c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/22/2026
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Applied Optoelectronics sets up $600M at-the-market stock offering
- Fannie Mae loses at least 10 senior executives amid departures - WSJ
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- Morgan Stanley course-corrects their semiconductor equipment outlook on demand
- One killed, three injured when man attacks Swedish school with sword
Palatin Reports First Quarter Fiscal Year 2024 Financial Results and Provides Corporate Update
November 14, 2023 7:30 AM ESTEnrollment Complete in Phase 3 PL9643 MELODY-1 Study in Dry Eye Disease (DED) 570 Patients EnrolledTopline Data Currently Expected Late 4Q Calendar Year 2023Phase 2 Clinical Study of Oral PL8177 in Patients with Ulcerative Colitis Interim Analysis Targeted for 1Q Calendar Year 2024Topline Results Currently Expected in 2Q Calendar Year 2024Vyleesi®Gross Product Revenue Increased 11% Over the Prior QuarterNet Product Revenue Increased 20% Over the Prior QuarterPrescriptions Dispensed Increased 14% Over the Prior... More
